...
首页> 外文期刊>Medicinal chemistry research: an international journal for rapid communications on design and mechanisms of action of biologically active agents >Computation of pharmacophore models for the prediction of mitogen-activated protein kinase activated protein kinase-2 inhibitory activity of pyrrolopyridines
【24h】

Computation of pharmacophore models for the prediction of mitogen-activated protein kinase activated protein kinase-2 inhibitory activity of pyrrolopyridines

机译:药效团模型的计算,预测吡咯并吡啶的促分裂原激活蛋白激酶激活蛋白激酶2抑制活性

获取原文
获取原文并翻译 | 示例
           

摘要

This article is an attempt to formulate the three-dimensional pharmacophore modelling of pyrrolopyridine derivatives inhibiting mitogen-activated protein kinase activated protein kinase-2 (MK_2). To understand the essential structural features for MK_2 inhibitors, pharmacophore hypothesis were built on the basis of a set of known MK_2 inhibitors selected from literature using PHASE program. Three pharmacophore models with one hydrogen-bond acceptor (A), two hydrogen-bond donors (D), one hydrophobic group (H) and one aromatic ring (R) as pharmacophoric features were developed. Amongst them the pharmacophore hypothesis ADDHR1 yielded a statistically significant 3D-QSAR model with 0.926 as R2 value and was considered to be the best pharmacophore hypothesis. The developed pharmacophore model was externally validated by predicting the activity of test set molecules. The squared predictive correlation coefficient of 0.882 was observed between experimental and predicted activity values of test set molecules. The geometry and features of pharmacophore was expected to be useful for the design of selective MK_2 inhibitors.
机译:本文试图建立吡咯并吡啶衍生物抑制丝裂原活化蛋白激酶活化蛋白激酶2(MK_2)的三维药效团模型。为了了解MK_2抑制剂的基本结构特征,在使用PHASE程序从文献中选择的一组已知MK_2抑制剂的基础上建立了药效团假说。建立了3个药效基团模型,以一个氢键受体(A),两个氢键供体(D),一个疏水基团(H)和一个芳环(R)作为药效学特征。其中,药效基团假设ADDHR1产生了具有统计学意义的3D-QSAR模型,R2值为0.926,被认为是最好的药效基团假设。通过预测测试集分子的活性,外部验证了开发的药效团模型。在测试集分子的实验活性值和预测活性值之间观察到平方的预测相关系数为0.882。预期药效基团的几何形状和特征可用于设计选择性MK_2抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号